Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akerley

Showing results (121-130 of 227) with videos related to

Pageof 23
Sort By:
Seminars in Radiation Oncology|April 21, 1999
Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV)H J Wanebo, P Chougule, N Ready, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?M J Glantz, B F Cole, L Recht, et al.
Cancer|June 15, 1995
Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow statusM J Glantz, W A Hall, B F Cole, et al.
Cancer Medicine|January 7, 2025
The Association Between Body Composition, Overall Survival, Treatment Decisions, and Patient-Reported Outcomes in Metastatic Non-Small-Cell Lung CancerAdriana M Coletta, Hyejung Lee, Sonam Puri, et al.
Mucosal Immunology|February 3, 2023
Antigen-specific memory Th17 cells promote cross-protection against nontypeable Haemophilus influenzae after mild influenza A virus infectionXinyun Zhang, Ying Yang, ShengSen Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 31, 2017
Tivantinib in Combination with Erlotinib versus Erlotinib Alone for EGFR-Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE StudyGiorgio V Scagliotti, Dale Shuster, Sergey Orlov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group BD M Savarese, S Halabi, V Hars, et al.
Omics : a Journal of Integrative Biology|March 11, 2003
H. influenzae Consortium: integrative study of H. influenzae-human interactionsEugene Kolker, Samuel Purvine, Alex Picone, et al.
Lung Cancer (Amsterdam, Netherlands)|November 4, 2025
The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR studyChristian Rolfo, David E Gerber, Rupesh Kotecha, et al.
Cancer|March 29, 2002
A multiinstitutional, concurrent chemoradiation trial of strontium-89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving boneWallace Akerley, James Butera, Terek Wehbe, et al.
Pageof 23

Showing results (121-130 of 227) with videos related to

Sort By:
Pageof 23
Seminars in Radiation Oncology|April 21, 1999
Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV)H J Wanebo, P Chougule, N Ready, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?M J Glantz, B F Cole, L Recht, et al.
Cancer|June 15, 1995
Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow statusM J Glantz, W A Hall, B F Cole, et al.
Cancer Medicine|January 7, 2025
The Association Between Body Composition, Overall Survival, Treatment Decisions, and Patient-Reported Outcomes in Metastatic Non-Small-Cell Lung CancerAdriana M Coletta, Hyejung Lee, Sonam Puri, et al.
Mucosal Immunology|February 3, 2023
Antigen-specific memory Th17 cells promote cross-protection against nontypeable Haemophilus influenzae after mild influenza A virus infectionXinyun Zhang, Ying Yang, ShengSen Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 31, 2017
Tivantinib in Combination with Erlotinib versus Erlotinib Alone for EGFR-Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE StudyGiorgio V Scagliotti, Dale Shuster, Sergey Orlov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group BD M Savarese, S Halabi, V Hars, et al.
Omics : a Journal of Integrative Biology|March 11, 2003
H. influenzae Consortium: integrative study of H. influenzae-human interactionsEugene Kolker, Samuel Purvine, Alex Picone, et al.
Lung Cancer (Amsterdam, Netherlands)|November 4, 2025
The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR studyChristian Rolfo, David E Gerber, Rupesh Kotecha, et al.
Cancer|March 29, 2002
A multiinstitutional, concurrent chemoradiation trial of strontium-89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving boneWallace Akerley, James Butera, Terek Wehbe, et al.
Pageof 23